Effect of Ondansetron on Prevention of Ventilator Associated Pneumonia in Intensive Care Unit Patients in Kashani Hospital in 2013
Introduction: Ventilator Associated Pneumonia (VAP) is the second most common infection with high mortality (24-50%). Ondansetron is a reliable and safe drug and it is currently used in the prevention of nausea and vomiting and has no side effects. Aim: The aim of the present study was to examin...
Main Authors: | Hossein Madineh, Omolbanin Rahimi, MohamadReza Abedin Zadeh, Majid Kabiri |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2017-08-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/10424/25859_CE[EK]_F(2)SS_PF1(EK_OM)_PF2(AK_EK_OM).pdf |
Similar Items
-
Severe Pneumonia in Neonates Associated with <i>Legionella pneumophila</i>: Case Report and Review of the Literature
by: Alba Perez Ortiz, et al.
Published: (2021-08-01) -
Knowledge and practices of intensive care unit nurses related to prevention of ventilator associated pneumonia in selected intensive care units of a tertiary care centre, India
by: Geetanjli Kalyan, et al.
Published: (2020-01-01) -
Update on ventilator-associated pneumonia [version 1; referees: 2 approved]
by: Jean-Francois Timsit, et al.
Published: (2017-11-01) -
Antibacterial therapy of community-acquired pneumonia in children
by: A.E. Abaturov, et al.
Published: (2018-08-01) -
Bacterial Profile of Ventilator-Associated Pneumonia and their Drug Susceptibility among Intensive Care Unit Patients
by: Fatemeh Barzegar, et al.
Published: (2023-09-01)